Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard Aplenc

Showing results (21-30 of 254) with videos related to

Pageof 26
Sort By:
Cancer Research|March 23, 2005
Methylenetetrahydrofolate reductase polymorphisms and therapy response in pediatric acute lymphoblastic leukemiaRichard Aplenc, Jennifer Thompson, Peggy Han, et al.
Pediatric Blood & Cancer|October 31, 2009
Pre-transplant lung function is predictive of survival following pediatric bone marrow transplantationJill P Ginsberg, Richard Aplenc, Joseph McDonough, et al.
Pediatric Blood & Cancer|April 17, 2014
TPMT and MTHFR genotype is not associated with altered risk of thioguanine-related sinusoidal obstruction syndrome in pediatric acute lymphoblastic leukemia: a report from the Children's Oncology GroupLisa Wray, Marijana Vujkovic, Thomas McWilliams, et al.
Plos One|September 17, 2013
Reasons for non-completion of health related quality of life evaluations in pediatric acute myeloid leukemia: a report from the Children's Oncology GroupDonna L Johnston, Rajaram Nagarajan, Mae Caparas, et al.
Blood|March 9, 2013
Effectiveness of supportive care measures to reduce infections in pediatric AML: a report from the Children's Oncology GroupLillian Sung, Richard Aplenc, Todd A Alonzo, et al.
Cancer Research|May 14, 2009
Host genetic variants in the interleukin-6 promoter predict poor outcome in patients with estrogen receptor-positive, node-positive breast cancerAngela DeMichele, Robert Gray, Michelle Horn, et al.
Leukemia Research Reports|November 26, 2015
Associations between genetic variants in folate and drug metabolizing pathways and relapse risk in pediatric acute lymphoid leukemia on CCG-1952Marijana Vujkovic, Aaron Kershenbaum, Lisa Wray, et al.
Pediatric Blood & Cancer|June 2, 2009
Flow cytometric determination of Src phosphorylation in pediatric patients treated with dasatinibBella S Guerrouahen, Eric Wieder, Elisabeth G Blanchard, et al.
Plos One|April 28, 2015
Patient-Reported Outcome Coordinator Did Not Improve Quality of Life Assessment Response Rates: A Report from the Children's Oncology GroupDonna Johnston, Robert Gerbing, Todd Alonzo, et al.
Journal of Cellular and Molecular Medicine|November 20, 2008
Association of human NAD(P)H:quinone oxidoreductase 1 (NQO1) polymorphism with development of acute lung injuryAnita J Reddy, Jason D Christie, Richard Aplenc, et al.
Pageof 26

Showing results (21-30 of 254) with videos related to

Sort By:
Pageof 26
Cancer Research|March 23, 2005
Methylenetetrahydrofolate reductase polymorphisms and therapy response in pediatric acute lymphoblastic leukemiaRichard Aplenc, Jennifer Thompson, Peggy Han, et al.
Pediatric Blood & Cancer|October 31, 2009
Pre-transplant lung function is predictive of survival following pediatric bone marrow transplantationJill P Ginsberg, Richard Aplenc, Joseph McDonough, et al.
Pediatric Blood & Cancer|April 17, 2014
TPMT and MTHFR genotype is not associated with altered risk of thioguanine-related sinusoidal obstruction syndrome in pediatric acute lymphoblastic leukemia: a report from the Children's Oncology GroupLisa Wray, Marijana Vujkovic, Thomas McWilliams, et al.
Plos One|September 17, 2013
Reasons for non-completion of health related quality of life evaluations in pediatric acute myeloid leukemia: a report from the Children's Oncology GroupDonna L Johnston, Rajaram Nagarajan, Mae Caparas, et al.
Blood|March 9, 2013
Effectiveness of supportive care measures to reduce infections in pediatric AML: a report from the Children's Oncology GroupLillian Sung, Richard Aplenc, Todd A Alonzo, et al.
Cancer Research|May 14, 2009
Host genetic variants in the interleukin-6 promoter predict poor outcome in patients with estrogen receptor-positive, node-positive breast cancerAngela DeMichele, Robert Gray, Michelle Horn, et al.
Leukemia Research Reports|November 26, 2015
Associations between genetic variants in folate and drug metabolizing pathways and relapse risk in pediatric acute lymphoid leukemia on CCG-1952Marijana Vujkovic, Aaron Kershenbaum, Lisa Wray, et al.
Pediatric Blood & Cancer|June 2, 2009
Flow cytometric determination of Src phosphorylation in pediatric patients treated with dasatinibBella S Guerrouahen, Eric Wieder, Elisabeth G Blanchard, et al.
Plos One|April 28, 2015
Patient-Reported Outcome Coordinator Did Not Improve Quality of Life Assessment Response Rates: A Report from the Children's Oncology GroupDonna Johnston, Robert Gerbing, Todd Alonzo, et al.
Journal of Cellular and Molecular Medicine|November 20, 2008
Association of human NAD(P)H:quinone oxidoreductase 1 (NQO1) polymorphism with development of acute lung injuryAnita J Reddy, Jason D Christie, Richard Aplenc, et al.
Pageof 26